Boston Financial Mangement LLC Amgen Inc Transaction History

Boston Financial Mangement LLC

  • $3.23 Billion
  • Q3 2024

A detailed history of Boston Financial Mangement LLC transactions in Amgen Inc stock. As of the latest transaction made, Boston Financial Mangement LLC holds 8,423 shares of AMGN stock, worth $2.34 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
8,423
Previous 8,546 1.44%
Holding current value
$2.34 Million
Previous $2.67 Million 1.61%
% of portfolio
0.08%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$309.38 - $337.38 $38,053 - $41,497
-123 Reduced 1.44%
8,423 $2.71 Million
Q2 2024

Jul 29, 2024
SELL
$262.75 - $319.31 $53,075 - $64,500
-202 Reduced 2.31%
8,546 $2.67 Million
Q1 2024

May 10, 2024
SELL
$268.87 - $324.56 $13,443 - $16,228
-50 Reduced 0.57%
8,748 $2.49 Million
Q4 2023

Feb 12, 2024
SELL
$255.7 - $288.46 $120,179 - $135,576
-470 Reduced 5.07%
8,798 $2.53 Million
Q3 2023

Nov 09, 2023
SELL
$218.65 - $271.46 $78,495 - $97,454
-359 Reduced 3.73%
9,268 $2.49 Million
Q2 2023

Aug 07, 2023
SELL
$214.27 - $253.37 $272,551 - $322,286
-1,272 Reduced 11.67%
9,627 $2.14 Million
Q1 2023

May 12, 2023
SELL
$225.79 - $275.2 $22,804 - $27,795
-101 Reduced 0.92%
10,899 $2.63 Million
Q4 2022

Jan 27, 2023
BUY
$229.03 - $291.01 $21,070 - $26,772
92 Added 0.84%
11,000 $0
Q3 2022

Nov 09, 2022
BUY
$224.46 - $253.15 $19,303 - $21,770
86 Added 0.79%
10,908 $2.46 Million
Q2 2022

Aug 08, 2022
BUY
$230.71 - $256.74 $84,439 - $93,966
366 Added 3.5%
10,822 $2.63 Million
Q1 2022

May 13, 2022
SELL
$219.27 - $242.57 $240,977 - $266,584
-1,099 Reduced 9.51%
10,456 $2.53 Million
Q4 2021

Feb 11, 2022
BUY
$198.88 - $227.6 $420,034 - $480,691
2,112 Added 22.37%
11,555 $2.6 Million
Q3 2021

Nov 12, 2021
BUY
$212.27 - $248.7 $131,607 - $154,194
620 Added 7.03%
9,443 $2.01 Million
Q2 2021

Aug 03, 2021
SELL
$233.58 - $259.14 $256,938 - $285,054
-1,100 Reduced 11.09%
8,823 $2.15 Million
Q1 2021

May 07, 2021
SELL
$221.91 - $258.6 $433,834 - $505,563
-1,955 Reduced 16.46%
9,923 $2.47 Million
Q4 2020

Feb 10, 2021
SELL
$216.38 - $257.67 $164,665 - $196,086
-761 Reduced 6.02%
11,878 $2.73 Million
Q3 2020

Nov 12, 2020
SELL
$234.65 - $260.95 $131,169 - $145,871
-559 Reduced 4.24%
12,639 $3.21 Million
Q2 2020

Aug 10, 2020
SELL
$197.81 - $242.74 $174,864 - $214,582
-884 Reduced 6.28%
13,198 $3.11 Million
Q1 2020

May 05, 2020
SELL
$182.24 - $241.7 $504,075 - $668,542
-2,766 Reduced 16.42%
14,082 $2.86 Million
Q4 2019

Feb 05, 2020
SELL
$189.21 - $243.2 $14,190 - $18,240
-75 Reduced 0.44%
16,848 $4.06 Million
Q3 2019

Nov 08, 2019
SELL
$174.11 - $208.62 $8,705 - $10,431
-50 Reduced 0.29%
16,923 $3.28 Million
Q2 2019

Jul 24, 2019
SELL
$166.7 - $195.41 $115,356 - $135,223
-692 Reduced 3.92%
16,973 $3.13 Million
Q1 2019

Apr 25, 2019
SELL
$180.87 - $203.88 $390,317 - $439,973
-2,158 Reduced 10.89%
17,665 $3.36 Million
Q4 2018

Jan 31, 2019
SELL
$178.4 - $208.25 $514,505 - $600,593
-2,884 Reduced 12.7%
19,823 $3.86 Million
Q3 2018

Nov 02, 2018
BUY
$185.29 - $208.89 $376,138 - $424,046
2,030 Added 9.82%
22,707 $4.71 Million
Q2 2018

Aug 03, 2018
SELL
$166.05 - $186.51 $56,457 - $63,413
-340 Reduced 1.62%
20,677 $3.82 Million
Q1 2018

Apr 25, 2018
SELL
$169.43 - $198.0 $517,439 - $604,692
-3,054 Reduced 12.69%
21,017 $3.58 Million
Q4 2017

Feb 05, 2018
SELL
$168.79 - $188.59 $60,595 - $67,703
-359 Reduced 1.47%
24,071 $4.19 Million
Q3 2017

Oct 30, 2017
BUY
$167.29 - $191.0 $4.09 Million - $4.67 Million
24,430
24,430 $4.56 Million

Others Institutions Holding AMGN

# of Institutions
3,078
Shares Held
405M
Call Options Held
7.56M
Put Options Held
7.16M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Boston Financial Mangement LLC Portfolio

Follow Boston Financial Mangement LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Financial Mangement LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Financial Mangement LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email